These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4092058)

  • 1. Increased agonist affinity is induced in tetranitromethane-modified muscarinic receptors.
    Gurwitz D; Sokolovsky M
    Biochemistry; 1985 Dec; 24(27):8086-93. PubMed ID: 4092058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rat brain and heart muscarinic receptors: modification with tetranitromethane.
    Gurwitz D; Sokolovsky M
    Biochem Biophys Res Commun; 1985 Sep; 131(3):1124-31. PubMed ID: 4052081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetranitromethane modification of the muscarinic receptors in bovine adrenal medulla.
    Yamanaka K; Muramatsu I; Kigoshi S
    Jpn J Pharmacol; 1988 Sep; 48(1):67-76. PubMed ID: 3199607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation by nicotine on binding of cerebral muscarinic receptors with muscarinic agonist and antagonist.
    Wang H; Cui WY; Liu CH
    Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):497-9. PubMed ID: 9863140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
    Ehlert FJ; Jenden DJ
    Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M; Waelbroeck M; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex.
    Forray C; el-Fakahany EE
    Mol Pharmacol; 1990 Jun; 37(6):893-902. PubMed ID: 2163015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of competition kinetics to investigate rat brain muscarinic receptors.
    Schreiber G; Henis YI; Sokolovsky M
    Isr J Med Sci; 1987; 23(1-2):36-43. PubMed ID: 3570744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alanine-scanning mutagenesis of transmembrane domain 6 of the M(1) muscarinic acetylcholine receptor suggests that Tyr381 plays key roles in receptor function.
    Ward SD; Curtis CA; Hulme EC
    Mol Pharmacol; 1999 Nov; 56(5):1031-41. PubMed ID: 10531410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of the muscarinic receptor by its endogenous neurotransmitter: binding of [3H]acetylcholine and its modulation by transition metal ions and guanine nucleotides.
    Gurwitz D; Kloog Y; Sokolovsky M
    Proc Natl Acad Sci U S A; 1984 Jun; 81(12):3650-4. PubMed ID: 6587380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pH on binding of agonists and antagonists to rat heart muscarinic receptors.
    Asselin J; Waelbroeck M; Robberecht P; de Neef P; Christophe J
    Biochem J; 1983 Oct; 216(1):11-9. PubMed ID: 6651771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations.
    Ladner CJ; Lee JM
    Exp Neurol; 1999 Aug; 158(2):451-8. PubMed ID: 10415152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of thermodynamic constants for agonist binding to muscarinic receptors from rat cerebral cortex.
    Hedlund B; Bartfai T
    Acta Chem Scand B; 1987 Mar; 41(3):225-7. PubMed ID: 3630522
    [No Abstract]   [Full Text] [Related]  

  • 14. Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors.
    Jakubík J; Bacáková L; El-Fakahany EE; Tucek S
    Mol Pharmacol; 1997 Jul; 52(1):172-9. PubMed ID: 9224827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition.
    McKinney M; Miller JH; Gibson VA; Nickelson L; Aksoy S
    Mol Pharmacol; 1991 Dec; 40(6):1014-22. PubMed ID: 1722002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical modification of rat cerebral cortex M1 muscarinic receptors: role of histidyl residues in antagonist and agonist binding.
    van Koppen CJ; Sokolovsky M
    Biochem Biophys Res Commun; 1988 Mar; 151(3):1069-73. PubMed ID: 3355543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist specific effects of guanine nucleotides on muscarinic cholinergic receptors in rat anterior pituitary membranes.
    Mukherjee A; Snyder GD
    Biochim Biophys Acta; 1981 Apr; 674(1):160-5. PubMed ID: 7236727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of p-chloromercuribenzoate on muscarinic receptors in the cerebral cortex.
    Birdsall NJ; Burgen AS; Hulme EC; Wong EH
    Br J Pharmacol; 1983 Sep; 80(1):187-96. PubMed ID: 6652369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Batrachotoxin changes the properties of the muscarinic receptor in rat brain and heart: possible interaction(s) between muscarinic receptors and sodium channels.
    Cohen-Armon M; Kloog Y; Henis YI; Sokolovsky M
    Proc Natl Acad Sci U S A; 1985 May; 82(10):3524-7. PubMed ID: 2582418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sialic acid is selectively involved in the interaction of agonists with M2 muscarinic acetylcholine receptors.
    Gies JP; Landry Y
    Biochem Biophys Res Commun; 1988 Jan; 150(2):673-80. PubMed ID: 3342042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.